World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03178747
Date of registration: 02/06/2017
Prospective Registration: No
Primary sponsor: Chulalongkorn University
Public title: Tzanck Smear With Methylene Blue Stain for Herpes
Scientific title: A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections
Date of first enrolment: March 7, 2017
Target sample size: 150
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03178747
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 3
Countries of recruitment
Thailand
Contacts
Name:     Pawinee Rerknimitr, MD, MSc
Address: 
Telephone: +6622564253
Email: pawinee.r@chula.ac.th
Affiliation: 
Name:     Pawinee Rerknimitr, MD, MSc
Address: 
Telephone: +6622564253
Email: pawinee.r@chula.ac.th
Affiliation: 
Name:     Pawinee Rerknimitr, MD, MSc
Address: 
Telephone:
Email:
Affiliation:  Chulalongkorn University
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients with clinically suspected of having herpes simplex, herpes zoster, varicella
zoster skin infections.

- Those who have vesicular skin lesion such as acute eczema, Paederus dermatitis.

- Those are well cooperative.

- Age > 18 years old.

Exclusion Criteria:

- Those who are not willing to have specimen from skin lesions to be collected.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Herpes Simplex
Herpes Zoster
Varicella Zoster
Intervention(s)
Diagnostic Test: Methylene blue
Diagnostic Test: Giemsa stain
Primary Outcome(s)
Sensitivity [Time Frame: 24 weeks]
Secondary Outcome(s)
Specificity [Time Frame: 24 weeks]
Factors that contribute the results from Methylene blue staining [Time Frame: 24 weeks]
Secondary ID(s)
674/59
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Dermatological Society of Thailand
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history